Loading

Panel: Beyond the hype: Where can AI (actually) take CGT

04 Sep 2025
Plenary
Plenary

AI is everywhere, but in CGT, real deployment remains limited. This session goes beyond the buzz to explore the tangible opportunities, early wins, and critical barriers to broader adoption.

We’ll look at where AI is beginning to make a difference and what’s still needed to move from isolated pilots to real impact. What kind of data, infrastructure, and cross-functional collaboration will unlock AI’s full potential in CGT?

Chairperson
Carmen Sanges, Scientific and Strategic Project Manager - Universitätsklinikum Würzburg
Speakers
Kat Kozyrytska, Founder - Cell Therapy Manufacturability Program
David Sourdive, Co-founder, Executive Vice President CMC & Manufacturing - Cellectis
Aaron Edwards, Co-founder & CEO - KiraGen Therapeutics